Between Two Benches: From Raw Startup to Industry Veteran
JLABS , 3210 Merryfield Row , San Diego , CA 92121
September 03, 2015 from 10:00 AM to 11:30 AM (PDT)
$10 - $35
Join us on September 3rd to hear firsthand how the multi-talented biotech veteran got to where she is today. Starting her biotech career as a researcher at Hybritech, San Diego's first biotech company, she developed technology for the PSA test used to detect the chemical marker of possible prostate cancer. She's been the CEO of Genoptix, which was taken public and eventually sold to Novartis. She has been named one of the Top 10 Women in Biotech by FierceBiotech and most recently worked at the DNA sequencing giant, Illumina. It wasn't an easy journey, but looking back she wouldn't have done it differently.
The Inspiring Leader Series provides an intimate forum for biotech veterans and experts to share their career successes and challenges. The accomplished speakers share their lessons learned throughout their professional adventure with an audience of entrepreneurs getting ready to embark on a similar path. The series is an interactive and inspiring experience.
Tina S. Nova, Ph.D. | Former Senior Vice President & General Manager, Oncology, Illumina read bio»
[interviewer] Diego Miralles, M.D. | Head, Johnson & Johnson Innovation read bio»
8:00 AM | Registration Opens, Breakfast, and Networking
8:30 AM | Presentation, Interview and Q&A
9:30 AM | Program Close
$35 | General Public
$20 | Student/Academic
$45 | At the door
3210 Merryfield Row
San Diego, CA
Tina S. Nova, Ph.D. | Former Senior Vice President & General Manager, Oncology, Illumina
Tina Nova is the former Senior Vice President and General Manager of Illumina's Oncology business, where she led the company's strategy for enabling the oncology community to develop innovative products across the full spectrum of cancer management based on Illumina next-generation sequencing technologies. Prior to joining Illumina in 2014, Nova co-founded the molecular diagnostics company Genoptix and served as its President, Chief Executive Officer, and Director from 2000 until the company was acquired by Novartis AG in 2011. She previously co-founded Nanogen Inc., a provider of molecular diagnostic tests and served as its Chief Executive Officer and President from 1994 until 2000. In addition, Nova held high-level positions with Selective Genomics, Ligand Pharmaceuticals, and Hybridtech (formerly a subsidiary of Eli Lilly & Company). She earned her B.S. in Biological Sciences from the University of California, Irvine and her Ph.D. in Biochemistry from the University of California, Riverside.
[interviewer] Diego Miralles, M.D. | Head, Johnson & Johnson Innovation
Diego Miralles, M.D., is Head, Johnson & Johnson Innovation, with responsibility for the regional innovation centers located in California, Boston, London and Asia Pacific, as well as JLABS incubators. Diego and his team are focused on accessing the most promising early stage external science and technology and developing collaborations across sectors between external innovators and the Johnson & Johnson Family of Companies. Diego has led a number of key innovation initiatives throughout the global Johnson & Johnson organization. As founding member of Johnson & Johnson Innovation, Diego played a leading role in launching the innovation center in California, and founded the JLABS incubator for life science companies, a model that has been replicated in five locations across North America. Diego established and led Janssen Healthcare Innovation which successfully launched patient-centric Care4Today™ solutions across North America and Europe that have delivered improved outcomes for patients and consumers in areas such as medication adherence, mental health, cardiovascular health and surgical recovery. Diego joined the healthcare industry more than 15 years ago after a dozen years in the hospital and academic worlds, including leading extensive clinical research, primarily focused on HIV/AIDS. Diego has extensive experience in clinical and basic research, including work on antiviral drug development at Tibotec, Trimeris, and Triangle Pharmaceuticals. He currently serves as an adjunct full professor in the Pharmacology Department at the University of California, San Diego (UCSD) and serves on the Board of the Rady Children's Hospital of San Diego and the UCSD Health System. Diego served on the faculty and in clinical practice at Duke University, Durham, NC. He completed his fellowship in Infectious Diseases at Cornell University-New York Hospital following a residency in Internal Medicine at the Mayo Clinic in Rochester, MN. Diego is a graduate of the University of Buenos Aires School of Medicine.
Connect with Diego: